Home › Funds › TCG Crossover Management, LLC › AKTS
TCG Crossover Management, LLC position in AKTS
AKTIS ONCOLOGY INC · Health Care
TCG Crossover Management, LLC reported holding 696,560 shares of AKTS (AKTIS ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$22.5M, representing 0.54% of its reported portfolio and ranking #39 among its reported holdings. TCG Crossover Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's AKTS position evolved
TCG Crossover Management, LLC first disclosed a stake in AKTS in Q2 2026 at 696,560 shares (US$22.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 696.56K | $22.45M | New |
About AKTS and 13F data
AKTS (AKTIS ONCOLOGY INC) is a Health Care company. 121 other funds we track also report a position in AKTS — the largest reported positions include MPM BioImpact LLC (US$155.9M), EcoR1 Capital, LLC (US$155.5M), Blue Owl Capital Holdings LP (US$99.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AKTS
- MPM BioImpact LLC 4.84M sh · $155.86M · Q2 2026
- EcoR1 Capital, LLC 4.82M sh · $155.49M · Q2 2026
- Blue Owl Capital Holdings LP 3.07M sh · $98.95M · Q2 2026
- RTW INVESTMENTS, LP 1.59M sh · $51.31M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.31M sh · $42.36M · Q2 2026
- BAKER BROS. ADVISORS LP 996.35K sh · $32.11M · Q2 2026
- Octagon Capital Advisors LP 960.85K sh · $30.97M · Q2 2026
- Merck & Co., Inc. 952.84K sh · $30.71M · Q2 2026
- Avidity Partners Management LP 484.20K sh · $15.61M · Q2 2026
- a16z Capital Management, L.L.C. 415.00K sh · $13.38M · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held AKTS?
TCG Crossover Management, LLC has disclosed AKTS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is TCG Crossover Management, LLC's current position in AKTS?
As of Q2 2026, TCG Crossover Management, LLC holds 696.56K shares of AKTS (AKTIS ONCOLOGY INC), valued at $22.45M, representing 0.54% of its reported portfolio and ranking #39.
Has TCG Crossover Management, LLC been buying or selling AKTS?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC newly opened its position in AKTS.
Which other funds hold AKTS?
Other major institutional holders of AKTS include MPM BioImpact LLC, EcoR1 Capital, LLC, Blue Owl Capital Holdings LP, among 121 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.